021-51111890
购物车（）
sales@molnova.cn
SU5208
CAS No. 62540-08-3
SU5208 ( 3-[(Thien-2-yl)methylene]-2-indolinone )
产品货号. M22956 CAS No. 62540-08-3
SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2414 | 有现货 |
|
| 10MG | ￥3645 | 有现货 |
|
| 25MG | ￥6010 | 有现货 |
|
| 50MG | ￥7995 | 有现货 |
|
| 100MG | ￥11259 | 有现货 |
|
| 500MG | ￥22842 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SU5208
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).
-
产品描述SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).
-
同义词3-[(Thien-2-yl)methylene]-2-indolinone
-
通路Angiogenesis
-
靶点VEGFR
-
受体VEGFR2
-
研究领域——
-
适应症——
化学信息
-
CAS Number62540-08-3
-
分子量227.28
-
分子式C13H9NOS
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CS3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Camila Mu?oz, et al. Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations. J Mol Graph Model. 2012 Feb;32:39-48.
产品手册
关联产品
-
Regorafenib
A potent multikinase inhibitor that potently inhibits these endothelial cell kinases in biochemical and cellular kinase phosphorylation assays with nanomolar range (IC50=3-200 nM).
-
Bevacizumab
Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.
-
Cediranib
A highly potent, orally bioavailable, pan-VEGFR inibitor with IC50 of 1, 5, 3 nM for VEGFR1, 2, 3, respectively.
